Frontiers in Pharmacology (Feb 2022)

Physiological Considerations for Modeling in vivo Antibody-Target Interactions

  • Tyler Dunlap,
  • Yanguang Cao,
  • Yanguang Cao

DOI
https://doi.org/10.3389/fphar.2022.856961
Journal volume & issue
Vol. 13

Abstract

Read online

The number of therapeutic antibodies in development pipelines is increasing rapidly. Despite superior success rates relative to small molecules, therapeutic antibodies still face many unique development challenges. There is often a translational gap from their high target affinity and specificity to the therapeutic effects. Tissue microenvironment and physiology critically influence antibody-target interactions contributing to apparent affinity alterations and dynamic target engagement. The full potential of therapeutic antibodies will be further realized by contextualizing antibody-target interactions under physiological conditions. Here we review how local physiology such as physical stress, biological fluid, and membrane characteristics could influence antibody-target association, dissociation, and apparent affinity. These physiological factors in the early development of therapeutic antibodies are valuable toward rational antibody engineering, preclinical candidate selection, and lead optimization.

Keywords